Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 48145 

1,008 hours to 999. There is no cost to respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

International Panel Physicans ........................ TB Indicators REDCap web form .................. 333 1 3 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–18539 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–1182] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Formative 

Research to Develop HIV Social 

Marketing Campaigns for Healthcare 

Providers’’ to the Office of Management 

and budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on March 8, 

2021 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Formative Research to Develop HIV 

Social Marketing Campaigns for 

Healthcare Providers (OMB Control No. 

0920–1182)—Reinstatement without 

Change—National Center for HIV/AIDS, 

Viral Hepatitis, STD and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

To address the HIV epidemic in the 

U.S., the Department of Health and 

Human Services launched Ending the 

HIV Epidemic: A Plan for America, 

which is a cross-agency initiative 

aiming to reduce new HIV infections in 

the U.S. by 90% by 2030. CDC’s Let’s 

Stop HIV Together campaign (formerly 

known as Act Against AIDS) is part of 

the national Ending the HIV Epidemic 

initiative and includes resources aimed 

at reducing HIV stigma and promoting 

testing, prevention, and treatment across 

the HIV care continuum. 

Within this context, CDC’s Division of 

HIV/AIDS Prevention (DHAP) has, and 

will continue implementing various 

communication initiatives to increase 

healthcare providers’ awareness of HIV 

testing-, prevention- and treatmentrelated topics; reduce new HIV 

infections among disproportionately 

impacted populations; and improve 

health outcomes for people living with 

HIV/AIDS in the US and its territories. 

Specifically, the initiatives target 

healthcare providers, including primary 

care, and relevant specialties such as 

HIV medicine and infectious disease, 

physicians, physician assistants, and 

nurses. 

The rounds of data collection include 

exploratory, message testing, concept 

testing, and materials testing. 

Information collected by DHAP will be 

used to assess healthcare providers’ 

informational needs about topics related 

to HIV testing, prevention, and 

treatment; pre-test campaign-related 

messages, concepts, and materials; and 

evaluate the extent to which the 

communication initiatives are reaching 

the target audiences and providing them 

with trusted HIV-related information. 

Data collections will include in-depth 

interviews and brief surveys. The data 

gathered under this request will be 

summarized in reports prepared for CDC 

by its contractor, such as quarterly and 

annual reports and topline reports that 

summarize results from each data 

collection. It is possible that data from 

this project will be published in peerreviewed manuscripts or presented at 

conferences, and the manuscripts and 

conference presentations may appear on 

the internet. 

The total estimated annualized 

burden hours are 902. Participation of 

respondents is voluntary, and there is 

no cost to participants other than their 

time. 


lotter on DSK11XQN23PROD with NOTICES1
48146 Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Health care providers ...................................... Study screener ............................................... 1,138 1 10/60 

Web-based survey ......................................... 569 1 15/60 

Exploratory Guide—Prevention with Positives 

In-depth Interview.

95 1 1 

Exploratory Guide—Patient Centered Care 

In-depth Interview.

95 1 1 

Exploratory Guide—HIV Prevention In-depth 

Interview.

95 1 1 

Message Testing In-depth Interview Guide ... 95 1 1 

Concept Testing In-depth Interview Guide .... 95 1 1 

Materials Testing In-depth Interview .............. 95 1 1 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–18540 Filed 8–26–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–21–0600; Docket No. CDC–2021– 

0087] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled CDC Model Performance 

Evaluation Program (MPEP) for 

Mycobacterium tuberculosis 

Susceptibility Testing information 

collection. CDC is requesting a threeyear approval for revision to the 

previously approved project used to 

monitor and evaluate performances and 

practices among national laboratories 

for M. tuberculosis susceptibility 

testing. 

DATES: CDC must receive written 

comments on or before October 26, 

2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2021– 

0087 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

CDC Model Performance Evaluation 

Program (MPEP) for Mycobacterium 

tuberculosis Susceptibility testing (OMB 

Control No. 0920–0600, Exp. 2/20/ 

2022)—Revision—National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Centers for Disease Control and 

Prevention (CDC) is requesting a 

revision to approved information 

collection from participants in the CDC 

Model Performance for Mycobacterium 

tuberculosis Drug Susceptibility Testing 

Program for a period of three years. 

Revision of this information will not 


lotter on DSK11XQN23PROD with NOTICES1